Ausgabe 2/2014
Inhalt (24 Artikel)
Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature
Ramin Sadeghi, Mehdi Asadi, Giorgio Treglia, Seyed Rasoul Zakavi, Asiehsadat Fattahi, David N. Krag
The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
Fausto Petrelli, Andrea Coinu, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Sandro Barni
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
J. Cortés, G. Curigliano, V. Diéras
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α
Ian N. Fleming, Alexandra Andriu, Tim A. D. Smith
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer
Mitsuchika Hosoda, Mitsugu Yamamoto, Kiichiroh Nakano, Kanako C. Hatanaka, Emi Takakuwa, Yutaka Hatanaka, Yoshihiro Matsuno, Hiroko Yamashita
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
Gladys Morrison, Xiaoyong Fu, Martin Shea, Sarmistha Nanda, Mario Giuliano, Tao Wang, Teresa Klinowska, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay
Fabrício F. T. Barros, Tarek M. A. Abdel-Fatah, Paul Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Andrew R. Green
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms
Kathleen A. Wilson-Edell, Mariya A. Yevtushenko, Daniel E. Rothschild, Aric N. Rogers, Christopher C. Benz
Dermcidin expression is associated with disease progression and survival among breast cancer patients
Heather Ann Brauer, Monica D’Arcy, Tanya E. Libby, Henry J. Thompson, Yutaka Y. Yasui, Nobuyuki Hamajima, Christopher I. Li, Melissa A. Troester, Paul D. Lampe
Benefit from anthracyclines in relation to biological profiles in early breast cancer
Andrea Rocca, Sara Bravaccini, Emanuela Scarpi, Anita Mangia, Stella Petroni, Maurizio Puccetti, Laura Medri, Luigi Serra, Monica Ricci, Serenella Cerasoli, Nicoletta Biglia, Roberta Maltoni, Donata Casadei Giunchi, Lorenzo Gianni, Amelia Tienghi, Mario Brandi, Monica Faedi, Piero Sismondi, Angelo Paradiso, Rosella Silvestrini, Dino Amadori
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
Andrea Rocca, Sara Bravaccini, Emanuela Scarpi, Anita Mangia, Stella Petroni, Maurizio Puccetti, Laura Medri, Luigi Serra, Monica Ricci, Serenella Cerasoli, Nicoletta Biglia, Roberta Maltoni, Donata Casadei Giunchi, Lorenzo Gianni, Amelia Tienghi, Mario Brandi, Marina Faedi, Piero Sismondi, Angelo Paradiso, Rosella Silvestrini, Dino Amadori
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
Andrea DeCensi, Zhuoxin Sun, Aliana Guerrieri-Gonzaga, Beat Thürlimann, Christina McIntosh, Carlo Tondini, Alain Monnier, Mario Campone, Marc Debled, Astrid Schönenberger, Khalil Zaman, Harriet Johansson, Karen N. Price, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, Stefan Aebi
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer
S. Irshad, C. Gillett, S. E. Pinder, R. P. A’Hern, M. Dowsett, I. O. Ellis, J. M. S. Bartlett, J. M. Bliss, A. Hanby, S. Johnston, P. Barrett-Lee, P. Ellis, A. Tutt
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study
Peyman Hadji, Annette Kauka, May Ziller, Katrin Birkholz, Monika Baier, Mathias Muth, Peter Kann
Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer
Ines Gruber, Tanja Fehm, Florin Andrei Taran, Markus Wallwiener, Markus Hahn, Diethelm Wallwiener, Natalia Krawzyck, Juergen Hoffmann, Andreas Daniel Hartkopf
Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial
Kerry S. Courneya, Roanne J. Segal, John R. Mackey, Karen Gelmon, Christine M. Friedenreich, Yutaka Yasui, Robert D. Reid, Diana Jespersen, Diane Cook, Carolyn Proulx, Linda Trinh, Lianne B. Dolan, Evyanne Wooding, Cynthia C. Forbes, Donald C. McKenzie
Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
L. J. Esserman, M. D. Alvarado, R. J. Howe, A. J. Mohan, B. Harrison, C. Park, C. O’Donoghue, E. M. Ozanne
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study
Aurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, Gérald Fioretta, Hyma Schubert, Christine Bouchardy, Pierre O. Chappuis, Simone Benhamou
The value of substratified combined imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses
Jiguang Li, Peng Xing, Liang Feng, Huiting Dong, Feng Jin, Yunfei Wu, Xinyu Zheng
Survival from breast cancer in patients with CHEK2 mutations
T. Huzarski, C. Cybulski, D. Wokolorczyk, A. Jakubowska, T. Byrski, J. Gronwald, P. Domagała, M. Szwiec, D. Godlewski, E. Kilar, E. Marczyk, M. Siołek, R. Wiśniowski, H. Janiszewska, D. Surdyka, R. Sibilski, P. Sun, J. Lubiński, S. A. Narod
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
Denise M. Boudreau, Onchee Yu, Jessica Chubak, Heidi S. Wirtz, Erin J. Aiello Bowles, Monica Fujii, Diana S. M. Buist
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer
Ya-Chen Tina Shih, Ying Xu, Wenli Dong, Fabrice Smieliauskas, Sharon Giordano, Yu Shen
Digoxin use and risk of invasive breast cancer: evidence from the Nurses’ Health Study and meta-analysis
Thomas P. Ahern, Rulla M. Tamimi, Bernard A. Rosner, Susan E. Hankinson
Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families
Tuomas Heikkinen, Sofia Khan, Elina Huovari, Sara Vilske, Johanna Schleutker, Anne Kallioniemi, Carl Blomqvist, Kristiina Aittomäki, Heli Nevanlinna